Global Pediatric High Flow Nasal Cannula Market Growth 2023-2029

Global Pediatric High Flow Nasal Cannula Market Growth 2023-2029

Pediatric high flow nasal cannula is a new non-invasive ventilation therapy that appears to be well tolerated in children. Recently, there has been a significant increase in the use of HFNC in pediatric and adult care settings. In recent decades, HFNC has been widely used in adult patients. Acute hypoxic respiratory failure, post-extubation support, preoxygenation before intubation or during bronchoscopy, postoperative respiratory failure, and acute pulmonary edema are indications with evidence in adults. Many pediatric studies have included patients with acute bronchiolitis. Other indications, such as asthma, sleep apnea, pneumonia, transport of critically ill patients, and post-extubation respiratory support, have been studied. Oxygen therapy using a heated, humidified high-flow nasal cannula (HHHFNC) provides warm, humidified oxygen at flow rates in excess of minute volume requirements. High oxygen concentration and positive intrathoracic airway pressure can be achieved at flow rates of 1 to 2 L/kg/min. Since its introduction to neonatal intensive care more than 20 years ago, HHHFNC therapy has been used more widely to help neonates, children and adults with severe respiratory distress avoid intubation or reintubation. Nasal cannulas with smaller pointed tips are used in pediatrics, carrying 0.5-1 liters of oxygen per minute for newborns, 1-2 liters of oxygen per minute for infants, and 1-4 liters of oxygen for older children. These pediatric nasal cannula devices are softer and gentler on the delicate facial skin of babies. These devices are made of lightweight tubes that can be easily wrapped around a patient's ear. One end of the tube goes into the nostril, while the other connects to the oxygen concentrator. There is a small chance of mucus blocking the airway.

LPI (LP Information)' newest research report, the “Pediatric High Flow Nasal Cannula Industry Forecast” looks at past sales and reviews total world Pediatric High Flow Nasal Cannula sales in 2022, providing a comprehensive analysis by region and market sector of projected Pediatric High Flow Nasal Cannula sales for 2023 through 2029. With Pediatric High Flow Nasal Cannula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric High Flow Nasal Cannula industry.

This Insight Report provides a comprehensive analysis of the global Pediatric High Flow Nasal Cannula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric High Flow Nasal Cannula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pediatric High Flow Nasal Cannula market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric High Flow Nasal Cannula and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric High Flow Nasal Cannula.

The global Pediatric High Flow Nasal Cannula market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Pediatric High Flow Nasal Cannula is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pediatric High Flow Nasal Cannula is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pediatric High Flow Nasal Cannula is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pediatric High Flow Nasal Cannula players cover Flexicare Medical Limited, Salter Labs, DeVilbiss Healthcare LLC, Besmed Health Business Corp., Fisher & Paykel Healthcare Limited, Medin Medical Innovations GmbH, Teleflex Incorporated, GaleMed Corporation and Neotech Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric High Flow Nasal Cannula market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Neonatal Nasal Cannula
Baby Nasal Cannula
Nasal Cannula for Children

Segmentation by application
Hospitals
Clinics
Care Centers
Homecare Settings
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Flexicare Medical Limited
Salter Labs
DeVilbiss Healthcare LLC
Besmed Health Business Corp.
Fisher & Paykel Healthcare Limited
Medin Medical Innovations GmbH
Teleflex Incorporated
GaleMed Corporation
Neotech Products
Hamilton Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pediatric High Flow Nasal Cannula market?

What factors are driving Pediatric High Flow Nasal Cannula market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pediatric High Flow Nasal Cannula market opportunities vary by end market size?

How does Pediatric High Flow Nasal Cannula break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.